News & Updates

Original New Drug Application Approvals by US FDA (1-15 March 2024)

Sacituzumab govitecan confers survival benefit in Asian patients with mBC

Sacituzumab govitecan improved progression-free survival (PFS) and overall survival (OS) in Asian patients with HR+/HER2– metastatic breast cancer (mBC) compared with the treatment of physician’s choice (TPC*), according to the EVER-132-002 study presented at ESMO Asia 2023.

Experts call for increased oral contraceptive use in China

Experts are calling for more education to increase the use of combination oral contraceptives (COCs) in China as up to 10 million abortions are performed each year for unwanted pregnancies.

Asian guidelines for the treatment of RA underway

The Asia Pacific League of Associations for Rheumatology (APLAR) is developing Asia’s first guideline recommendations for the treatment of rheumatoid arthritis (RA).

Dry needle technique relieves chronic upper back pain

The dry needle technique is an effective treatment modality for alleviating chronic upper back pain, new research has shown.

Home-based rehabilitation technologies gain ground

Innovations in home-based rehabilitation technologies are gaining popularity now as alternative solutions to providing health care services to an aging population are being sought. One such innovation is telerehabilitation or the practice of providing rehabilitation services over a distance through the use of information and communications technology such as the Internet. Consultative, preventive, diagnostic and therapeutic services are provided to patients via two-way interactive telecommunication technology.

HSA recalls 8 brands of ranitidine products islandwide

The Singapore Health Sciences Authority (HSA) has recalled eight brands of ranitidine products containing trace amounts of the nitrosamine impurity NDMA*, which is a potential human carcinogen.

Interactive learning styles provide optimal learning opportunities

Interactive teaching strategies can improve medical education in rehabilitation medicine, according to Dr. Ian Cameron, chairman of the Department of Rehabilitation Medicine, Sydney Medical School - University of Sydney.